|
|
||||||||
The Journal of Immunology, Vol 148, Issue 6 1737-1745, Copyright © 1992 by American Association of Immunologists
ARTICLES |
T Suda and A Zlotnik
DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94304.
We previously reported that IL-7 maintains the viability and differentiation potential of CD25 (IL-2R p55) positive CD3-CD4-CD8- thymic pre-T cells in vitro. This culture system is suitable for studying signals that regulate differentiation of T cell precursors in the thymus. In this study, we screened cytokines for their capacity to induce CD4 or CD8 in murine thymic pre-T cells cultured with IL-7. Of 15 cytokines tested, only transforming growth factor (TGF-beta) and TNF- alpha induced CD8 (Lyt-2), while no cytokine was able to induce CD4 on CD25+CD3-CD4-CD8- thymocytes. The combination of TGF-beta and TNF-alpha was synergistic, and the majority of cells recovered after 2 to 3 days in culture expressed CD8 (but not CD3 or CD4). A similar effect of TGF- beta and TNF-alpha was observed using day-15 fetal thymocytes, CD3+CD4- CD8- or CD3+CD4+CD8- adult thymocytes, although the combination of these cytokines resulted in an additive rather than a synergistic effect in these subsets. In contrast, neither TGF-beta nor TNF-alpha induced CD8 expression on splenic CD4+CD8- T cells. These observations suggest a role for these cytokines in the induction of CD8 expression in CD8- thymocyte subsets including CD3-CD4-CD8- thymic pre-T cells.
This article has been cited by other articles:
![]() |
A. Rosendahl, M. Speletas, K. Leandersson, F. Ivars, and P. Sideras Transforming growth factor-{beta}- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis Int. Immunol., December 1, 2003; 15(12): 1401 - 1414. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Horwitz, S. G. Zheng, and J. D. Gray The role of the combination of IL-2 and TGF-{beta} or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets J. Leukoc. Biol., October 1, 2003; 74(4): 471 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Bollard, C. Rossig, M. J. Calonge, M. H. Huls, H.-J. Wagner, J. Massague, M. K. Brenner, H. E. Heslop, and C. M. Rooney Adapting a transforming growth factor beta -related tumor protection strategy to enhance antitumor immunity Blood, May 1, 2002; 99(9): 3179 - 3187. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. R. Carrasco, C. Trigueros, A. R. Ramiro, V. G. de Yebenes, and M. L. Toribio beta -Selection Is Associated With the Onset of CD8beta Chain Expression on CD4+CD8alpha alpha + Pre-T Cells During Human Intrathymic Development Blood, November 15, 1999; 94(10): 3491 - 3498. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kakinuma, Y. Hamada, Y. Futamura, C. Kuwayama, A. Shimoi, and Y. Shibutani Human Natural Tumor Necrosis Factor {alpha} Induces Multiple Endocrine and Hematologic Disorders in Rats Toxicol Pathol, July 1, 1999; 27(4): 402 - 411. [Abstract] [PDF] |
||||
![]() |
Z.-W. Lai, C. Hundeiker, E. Gleichmann, and C. Esser Cytokine Gene Expression during Ontogeny in Murine Thymus on Activation of the Aryl Hydrocarbon Receptor by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Mol. Pharmacol., July 1, 1997; 52(1): 30 - 37. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |